Cognoptix is a biotechnology company that develops a non-invasive eye scanning test. It is designed to aid in the early detection and diagnosis of Alzheimer’s disease. The company provides technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye as well as to examine and measure deposits in specific areas of the lens.